Rabi Hanna: Excited to Participate in ASH-a-palooza at ASH25 / OncoDaily

oncodaily - Rabi Hanna, Chairman at Department of Pediatric Hematology-Oncology and BMT at Cleveland Clinic, shared a post on X: “Excited to participate in ASH-a-palooza at ASH25 BLOOD BUDDIES. Designed for undergraduates, medical […]

#healthcare


ASH25 Conference Buzz

Inside ASH25 with Sanam Loghavi

3 months / oncodaily

Rabi Hanna: An Inspiring Start to ASH-a-Palooza Led by Dr. Rayne Rouce at ASH25

3 months / oncodaily

Naveen Pemmaraju: Thrilled to Moderate PER MPN Session at ASH25

3 months / oncodaily

Mohamad Mohty: Honored to be “ASH’d”

3 months / oncodaily

Kimryn Rathmell: World-Class Hematology Oncology Science from The James Team at ASH25

3 months / oncodaily

Sridevi Rajeeve: All-Stars from Across Hematologic Malignancies at the ASH25 HealthTree Foundation Reception

3 months / oncodaily

Rabi Hanna: Excited to Participate in ASH-a-palooza at ASH25

3 months / oncodaily

Amer Zeidan: Easiest Conference Badge Pickup at ASH25

3 months / oncodaily


ASH25 Research Highlights

Jordan Gauthier: Our Two Presentations Focused on CAR T-Cell Safety at ASH 2025

3 months / oncodaily

Andres Gomez։ The 2025 ASH Guidelines for Older Adults with AML Are Now Out

3 months / oncodaily

Vincent Rajkumar: How to Use MRD Assessment in Practice and Research

3 months / oncodaily


Other

Journalists Dig Into Maine HIV Outbreak and Ever-Closer End to Enhanced ACA Subsidies

3 months / kffhealthnews


Pharma Innovations at ASH25

#ASH25: AstraZeneca's dual-targeting CAR-T sees similar responses in Western patients as in China

3 months / endpoints / Max Gelman

#ASH25: As one door closes for Regeneron’s lymphoma bispecific, another reopens

3 months / endpoints / Lei Lei Wu


All Other Stories

J&J joins 'menin party' at ASH; GSK to work with Oxford BioTherapeutics

3 months / endpoints / ENDPOINTS

Charles Gaulin: Preexisting Mental Health Disorders and Immune Effector Cell Therapy Outcomes at ASH25

3 months / oncodaily

Saurabh Zanwar Shares Key Insights from ASH25 Poster Sessions

3 months / oncodaily

Yazan Madanat: Kelly Bolton Delivers ASH25 Plenary on Therapy-Related Myeloid Neoplasms

3 months / oncodaily

Michael Kühn: Johanna Rausch Highlights Menin Inhibitors Sensitizing AML to CAR-T at ASH25

3 months / oncodaily

Talha Badar: ASH25 Highlights DDX41-Mutant HR-MDS and AML Insights

3 months / oncodaily

Rabi Hanna: Paulina Velasquez Highlights CAR T Cell Strategies in AML at ASH25

3 months / oncodaily

Stephen Oh: Spotlight on Hematology Faculty at ASH25

3 months / oncodaily

#ASH25: Star Therapeutics details early data for blood disorder shot, weighs IPO

3 months / endpoints / Lei Lei Wu

Charles Gaulin: New Data on Extranodal Disease and CAR T Outcomes

3 months / oncodaily

Mohit Manrao: Showcasing AstraZeneca’s Latest Science in Redefining Blood Cancer Care at ASH25

3 months / oncodaily

Stephen Oh: Celebrating All of the MPN Heroes at ASH25

3 months / oncodaily

Jan Geissler: From First Advocacy Meeting to Presenting a CML Patient Preference Study at ASH 2025

3 months / oncodaily

Saturday, December 6, 2025, 7:21 am / permalink 16654 / 27 stories in 3 months



Related Stories



Related Tags


Healthcare

Judge orders Leapfrog to remove safety grades for five Florida hospitals (22 hrs)

Daily multivitamin slows epigenetic aging in randomized COSMOS analysis (41 hrs)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

more #healthcare


StackHealth Time Machine



NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.